1,4-Bis((1H-imidazol-1-yl)methyl)benzene

Catalog No. :
ACTJRE597
CAS No. :
56643-83-5
Molecular Formula :
C14H14N4
Molecular Weight :
238.29

IUPAC Name:1,4-bis((1H-imidazol-1-yl)methyl)benzene

1,4-Bis((1H-imidazol-1-yl)methyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$117.00Login to see priceIn stockIn stock
25g97%$504.00Login to see priceIn stockIn stock
100g97%$1508.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Bis((1H-imidazol-1-yl)methyl)benzene
IUPAC Name1,4-bis((1H-imidazol-1-yl)methyl)benzene
MDL No.MFCD06598031
Molecular FormulaC14H14N4
Molecular Weight238.29
SMILESC1(CN2C=CN=C2)=CC=C(CN3C=CN=C3)C=C1
InChI KeyNKUFFYFOBGGDTP-UHFFFAOYSA-N
Synonym1,4-bis(imidazol-1-ylmethyl)benzene | 1,4-Bis[(1H-imidazol-1-yl)methyl]benzene | 1-[[4-(imidazol-1-ylmethyl)phenyl]methyl]imidazole | 1,4-Bis(imidazole-l-ylmethyl)benzene | 1,4-Bis((1H-imidazol-1-yl)methyl)benzene | α,α'-Bis[(1-imidazolyl)methyl]-p-xylene
CAS No.56643-83-5
PubChem CID1257389

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTJRE597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACTJRE597 route product structure diagram
    ACTJRE59756643-83-5 In Stock
Inquiry

2. ACTJRE597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACTJRE597 route product structure diagram
    ACTJRE59756643-83-5 In Stock
Inquiry

Comments (0)